All News
Filter News
Found 808,690 articles
-
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview
12/14/2023
Morphogenesis, Inc., a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, announced its corporate rebranding and provided a business overview.
-
Feinstein Institutes, Molecular Medicine award Dr. Peter Hotez with 2023 Cerami Award
12/14/2023
The Feinstein Institutes for Medical Research and Molecular Medicine announced that Peter Hotez, MD, PhD, a distinguished immunologist, pediatrician, and global health advocate, has been awarded the Anthony Cerami Award in Translational Medicine for his outstanding contributions to the field of molecular medicine and his dedication to addressing global health challenges.
-
Rapid Growth at Attune Medical Spurs Strategic Hires and Expansion
12/14/2023
Attune Medical, a pioneer in utilizing the esophageal space to proactively manage patient temperature and to reduce the likelihood of esophageal injury during cardiac ablation procedures, announces significant growth with three key additions and expansion of commercial operations.
-
Where Patients Live Impacts Whether They Pick Up Their Heart-Failure Medications
12/14/2023
People who live in neighborhoods with higher levels of poverty and unemployment are less likely to fill their heart-failure drug prescriptions than those living in wealthier areas, a new study shows.
-
Joint Federal Operation Results in Seizure of More Than $18 Million in Illegal E-Cigarettes
12/14/2023
The U.S. Food and Drug Administration, in collaboration with U.S. Customs and Border Protection, announced the seizure of approximately 1.4 million units of unauthorized e-cigarette products, including brands such as Elf Bar, which according to the 2023 National Youth Tobacco Survey, is the most commonly used brand among youth e-cigarette users.
-
Thomas Jefferson University Names Said Ibrahim, MD, MBA, MPH the Anthony F. and Gertrude M. DePalma Dean of Sidney Kimmel Medical College
12/14/2023
On December 1, Jefferson welcomed newly appointed Anthony F. and Gertrude M. DePalma Dean of Thomas Jefferson University's esteemed Sidney Kimmel Medical College and president of Jefferson University Physicians, Said Ibrahim, MD, MBA, MPH.
-
Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
12/14/2023
Median Technologies and PASREL-Imagerie, announce the signing of an agreement to deliver cutting-edge imaging biomarkers for the development of new oncology drugs in the era of precision medicine.
-
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed
12/14/2023
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its proposal to acquire Volpara Health Technologies Ltd., a global leader in AI-enabled software for the early detection and prevention of cancer.
-
ROME Publishes Landmark Nature Paper Revealing First High-Resolution Structure of LINE-1 Reverse Transcriptase (RT) for Drug Discovery
12/14/2023
ROME Therapeutics announced a landmark publication in Nature revealing the first high-resolution structure of the LINE-1 reverse transcriptase.
-
FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals
12/14/2023
The U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law.
-
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
12/14/2023
Adela, Inc. announced the appointment of Lisa Alderson as Chief Executive Officer, following an extensive, nationwide search.
-
Lung Cancer Research Foundation Announces 2023 Scientific Research Grant Awards
12/14/2023
The Lung Cancer Research Foundation® is pleased to announce the awardees of its 2023 Scientific Grant Program.
-
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 14, 2023
12/14/2023
DermTech, Inc. announced the grant to 15 new employees of restricted stock units representing the contingent right to receive up to an aggregate of 56,230 shares of the Company’s common stock under its 2022 Inducement Equity Incentive Plan, as amended, or the 2022 Inducement Plan.
-
Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs
12/14/2023
The Japan-based Global Health Innovative Technology Fund announced that it will invest approximately US$3.3 million in a global multicenter Phase III clinical trial project led by Fosun Pharma for a triple artemisinin combination drug against malaria in Africa and Southeast Asia, to accelerate the development and commercialization of this new drug.
-
Histogen Announces Second Adjournment of Special Meeting of Stockholders
12/14/2023
Histogen Inc., announced that its special meeting of stockholders has been adjourned to Thursday, January 4, 2024 at 8:00 a.m. Pacific Time with respect to both proposals described in its definitive proxy statement filed with the U.S. Securities and Exchange Commission on October 18, 2023.
-
Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis
12/14/2023
Agomab Therapeutics NV announced that it has dosed the first subject in a first-in-human Phase 1 clinical study of AGMB-447, an inhaled lung-restricted small molecule inhibitor of ALK5.
-
Ionis announces the appointment of Michael Yang to Board of Directors
12/14/2023
Ionis Pharmaceuticals, Inc. announced the appointment of Michael Yang, an experienced biopharmaceutical executive, to the Ionis Board of Directors.
-
Nerviano Medical Sciences and Italfarmaco Announce Licensing of Linker-Payload Technology to Develop and Commercialize a Novel Peptide-Drug Conjugate
12/14/2023
Nerviano Medical Sciences S.r.l., a clinical-stage biotechnology company member of NMS group, announced the signing of a license agreement with Italfarmaco S.p.A., a specialty pharmaceutical company, to develop and commercialize a novel peptide-drug conjugate.
-
Brenus Pharma Joins the Paris Saclay Cancer Cluster (PSCC) to Collaborate at the Heart of Innovation in Oncology
12/14/2023
Brenus Pharma has successfully joined the Paris Saclay Cancer Cluster, the first national Onco-cluster.
-
Syndax Announces Proposed $150 Million Public Offering of Common Stock
12/14/2023
Syndax Pharmaceuticals, Inc. announced that it plans to offer and sell, subject to market and other conditions, $150 million of shares of its common stock in an underwritten public offering.